• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.成年斯里兰卡炎症性肠病患者的骨质疏松症
World J Gastroenterol. 2009 Jul 28;15(28):3528-31. doi: 10.3748/wjg.15.3528.
2
Prevalence of low bone mineral density in inflammatory bowel disease and factors associated with it.炎症性肠病患者的低骨密度患病率及其相关因素。
Indian J Gastroenterol. 2020 Aug;39(4):346-353. doi: 10.1007/s12664-020-01048-5. Epub 2020 Sep 17.
3
Analysis of risk factors for low bone mineral density in inflammatory bowel disease.炎症性肠病患者低骨密度的危险因素分析
Digestion. 2006;73(1):40-6. doi: 10.1159/000092013. Epub 2006 Mar 14.
4
Bone density improves with disease remission in patients with inflammatory bowel disease.炎症性肠病患者的骨密度会随着疾病缓解而改善。
Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1267-73. doi: 10.1097/00042737-200312000-00003.
5
Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.炎症性肠病患者长期缓解后骨量减少和骨髓脂肪组织保留。
Osteoporos Int. 2017 Jul;28(7):2167-2176. doi: 10.1007/s00198-017-4014-3. Epub 2017 Apr 12.
6
The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease.炎症性肠病患者骨质疏松症的患病率及危险因素
Bratisl Lek Listy. 2013;114(8):439-45. doi: 10.4149/bll_2013_092.
7
Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?炎症性肠病患者骨质疏松的治疗:男性患者的护理存在未满足的需求?
J Crohns Colitis. 2013 Dec;7(11):901-7. doi: 10.1016/j.crohns.2012.12.008. Epub 2013 Jan 18.
8
[Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].[炎症性肠病所致骨质流失:前瞻性研究,50例]
Tunis Med. 2009 Feb;87(2):144-8.
9
Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.炎症性肠病患者血清中凯莫瑞蛋白、内脂素和内脏脂肪素水平与骨密度的关系
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):814-9. doi: 10.1097/MEG.0000000000000617.
10
Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.中国炎症性肠病成年患者的维生素 D 水平和骨代谢。
J Dig Dis. 2014 Mar;15(3):116-23. doi: 10.1111/1751-2980.12118.

引用本文的文献

1
Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis.两样本孟德尔随机化分析评估炎症性肠病和骨质疏松症之间的因果关联。
Front Public Health. 2023 May 26;11:1151837. doi: 10.3389/fpubh.2023.1151837. eCollection 2023.
2
Bone alterations in inflammatory bowel diseases.炎症性肠病中的骨骼改变
World J Clin Cases. 2019 Aug 6;7(15):1908-1925. doi: 10.12998/wjcc.v7.i15.1908.
3
Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain.来自西班牙的炎性肠病患者的代谢性骨病
Therap Adv Gastroenterol. 2019 Jul 31;12:1756284819862152. doi: 10.1177/1756284819862152. eCollection 2019.
4
Correlation between low bone density and disease activity in patients with ulcerative colitis.溃疡性结肠炎患者低骨密度与疾病活动度之间的相关性。
Middle East J Dig Dis. 2015 Jan;7(1):25-30.
5
[The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].[慢性炎症性肠病中骨密度降低:患病率及危险因素]
Pan Afr Med J. 2013 Jun 25;15:70. doi: 10.11604/pamj.2013.15.70.2859. eCollection 2013.
6
The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.土耳其东部初诊溃疡性结肠炎患者骨矿物质密度降低的患病率及危险因素
Int J Clin Exp Med. 2011;4(2):157-63. Epub 2011 Apr 3.

本文引用的文献

1
Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women.超声和骨密度测定法用于绝经后妇女骨质疏松症筛查的成本效益
Appl Health Econ Health Policy. 2008;6(2-3):113-35. doi: 10.1007/BF03256127.
2
Race and diet interactions in the acquisition, maintenance, and loss of bone.种族与饮食在骨骼获取、维持及流失方面的相互作用。
J Nutr. 2008 Jun;138(6):1256S-60S. doi: 10.1093/jn/138.6.1256S.
3
Emergence of inflammatory bowel disease 'beyond the West': do prosperity and improved hygiene have a role?炎症性肠病在“西方以外”地区的出现:繁荣与卫生条件改善是否起了作用?
Trans R Soc Trop Med Hyg. 2008 Sep;102(9):857-60. doi: 10.1016/j.trstmh.2008.03.016. Epub 2008 May 2.
4
Gut, inflammation and osteoporosis: basic and clinical concepts.肠道、炎症与骨质疏松症:基础与临床概念
Gut. 2008 May;57(5):684-94. doi: 10.1136/gut.2006.117382.
5
Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients.比较T值和Z值在识别炎症性肠病患者骨质疏松风险因素中的作用。
J Musculoskelet Neuronal Interact. 2008 Jan-Mar;8(1):79-84.
6
A 2008 panorama on osteoporosis and inflammatory bowel disease.2008年骨质疏松症与炎症性肠病全景综述。
Minerva Med. 2008 Feb;99(1):65-71.
7
Basic and clinical aspects of osteoporosis in inflammatory bowel disease.炎症性肠病中骨质疏松症的基础与临床研究
World J Gastroenterol. 2007 Dec 14;13(46):6156-65. doi: 10.3748/wjg.v13.i46.6156.
8
[Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006].[骨折的绝对风险与世界卫生组织指南。世界卫生组织推荐的骨折风险评估以及《2006年日本骨质疏松症防治指南》]
Clin Calcium. 2007 Jul;17(7):1022-8.
9
Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.炎症性肠病中骨与矿物质代谢的评估:病例系列及综述
Endocr Pract. 2006 Nov-Dec;12(6):622-9. doi: 10.4158/EP.12.6.622.
10
Bone density testing in clinical practice.临床实践中的骨密度检测
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):586-95. doi: 10.1590/s0004-27302006000400004.

成年斯里兰卡炎症性肠病患者的骨质疏松症

Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

作者信息

de Silva Arjuna Priyadarsin, Karunanayake Aranjan Lionel, Dissanayaka Thalahitiya Gamaralalage Iruka, Dassanayake Anuradha Supun, Duminda Hewa Kattadi Kankanamgae Tilak, Pathmeswaran Arunasalam, Wickramasinghe Ananda Rajitha, de Silva Hithanadura Janaka

机构信息

Department of Medicine, Faculty of Medicine, University of Kelaniya, PO Box 6, Thalagolla Road, Ragama GQ11010, Sri Lanka.

出版信息

World J Gastroenterol. 2009 Jul 28;15(28):3528-31. doi: 10.3748/wjg.15.3528.

DOI:10.3748/wjg.15.3528
PMID:19630109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2715980/
Abstract

AIM

To determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in adult Sri Lankans.

METHODS

We identified eligible subjects from among consecutive patients diagnosed with IBD who attended our outpatient clinic. We included only patients aged between 20 and 70 years. Patients who were pregnant, had significant comorbidity, or were on calcium supplements or treatment for osteoporosis within the past 6 mo, were excluded. Healthy, age- and sex-matched controls were also recruited, in a control to patient ratio of 3:1. Both groups were screened for osteoporosis using peripheral dual energy X-ray absorptiometry scanning.

RESULTS

The study population consisted of 111 IBD patients (male:female = 43:68; mean age 42.5 years) and 333 controls (male:female = 129:204; mean age 43.8 years). The occurrence of osteoporosis among IBD patients (13.5%) was significantly higher than among controls (4.5%) (P = 0.001). The frequency of osteoporosis was not significantly different between ulcerative colitis (14.45%) and Crohn's disease (10.7%). However, on multivariate analysis, only age (P = 0.001), menopause (P = 0.024) and use of systemic steroids (P < 0.001) were found to be associated independently with the occurrence of osteoporosis, while IBD, severity of disease, number of relapses, duration of illness or treatment other than systemic steroids were not.

CONCLUSION

IBD does not appear to be an independent risk factor for the occurrence of osteoporosis in this population. However, the use of systemic steroids was a risk factor.

摘要

目的

确定炎症性肠病(IBD)是否为成年斯里兰卡人骨质疏松症的危险因素。

方法

我们从连续就诊于我院门诊并被诊断为IBD的患者中确定符合条件的受试者。仅纳入年龄在20至70岁之间的患者。排除怀孕、有严重合并症或在过去6个月内服用钙补充剂或接受骨质疏松症治疗的患者。还招募了年龄和性别匹配的健康对照,对照与患者的比例为3:1。两组均采用外周双能X线吸收法扫描筛查骨质疏松症。

结果

研究人群包括111例IBD患者(男:女 = 43:68;平均年龄42.5岁)和333例对照(男:女 = 129:204;平均年龄43.8岁)。IBD患者中骨质疏松症的发生率(13.5%)显著高于对照组(4.5%)(P = 0.001)。溃疡性结肠炎(14.45%)和克罗恩病(10.7%)之间骨质疏松症的发生率无显著差异。然而,多因素分析显示,仅年龄(P = 0.001)、绝经(P = 0.024)和全身用类固醇的使用(P < 0.001)与骨质疏松症的发生独立相关,而IBD、疾病严重程度、复发次数、病程或全身用类固醇以外的治疗则无关。

结论

在该人群中,IBD似乎不是骨质疏松症发生的独立危险因素。然而,全身用类固醇的使用是一个危险因素。